We are international
Donate
• about imf TEXT SIZE   
Scientific Advisory Board

SCIENTIFIC ADVISORY BOARD

The IMF is fortunate to have a distinguished Board Of Scientific Advisors comprised of 47 members, who are world recognized experts in the field of multiple myeloma. This board provides valuable counsel and supports the IMF's goals in education, treatment and research.

Chairman
Scientific Advisors
Scientific Advisors Emeriti
Raymond Alexanian, MD
M.D. Anderson Cancer Center
Houston, TX
U.S.A.
Kenneth C. Anderson, MD
Dana-Farber Cancer Institute
Boston, MA
U.S.A.

Michel Attal, MD
Hôpital Purpan
Toulouse, France
Hervé Avet-Loiseau, MD
Institut de Biologie, Nantes, France

Dalsu Baris, MD, PhD
Staff Scientist
Division of Cancer Epidemiology
National Cancer Institute (NCI)
Bethesda, Maryland
USA
Bart Barlogie, MD, PhD
Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences
Little Rock, Arkansas

U.S.A.

Régis Battaile, MD
Central Laboratory of Hematology
Institute of Biology
Nantes, France
Meral Beksaç, MD
Ankara University
Ibn Sina Hospital
Ankara, Turkey

William Bensinger, MD
University of Washington
Fred Hutchinson Cancer Research Center
Seattle , WA
U.S.A.
James R. Berenson, MD
Institute for Myeloma & Bone Cancer Research
Los Angeles, CA
U.S.A.

P. Leif Bergsagel, MD
Mayo Clinic
Scottsdale, AZ
USA
Joan Bladé, MD
Hospital Clinic
Hematology
Barcelona, Spain

Mario Boccadoro, MD
Cattedra Di Ematologia
Torino, Italy
J. Anthony Child, MD
Chief Investigator of the MRC Myeloma IX Study
Clinical Trials and Research Unit
University of Leeds
Leeds, U.K.

Raymond L. Comenzo, MD
Tufts University Medical Center
Boston, Massachusetts
John Crowley, PhD
Cancer Research and Biostatistics (CRAB)
Seattle, Washington, U.S.A.

Franco Dammacco, MD
University of Bari Medical School
Bari, Italy
Faith Davies, MD
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, UK

Meletios-Athanassios Dimopoulos, MD
Alexandra Hospital
Athens, Greece
Johannes Drach, MD
University Hospital Vienna
Vienna, Austria

Brian G.M. Durie, MD
Cedars-Sinai Comprehensive Cancer Center
Los Angeles, CA
U.S.A.
Hermann Einsele, MD
Hermann Einsele, MD
Universitätsklinikums Würzburg
(University Clinic of Wuerzburg)
Würzburg, Germany

Dorotea Fantl, MD
Sociedad Argentinade Hematolgia
Buenos Aries, Argentina
Rafael Fonseca, MD
The Mayo Clinic
Scottsdale, Arizona

Gösta Gahrton, MD
Karolinska Institute
Huddinge University Hospital
Stockholm, SWEDEN
Morie A. Gertz, MD
Mayo Clinic
Rochester, MN
U.S.A.

John Gibson, MD
Royal Prince Alfred Hospital
Camperdown, NSW, Australia
Hartmut Goldschmidt, MD
Medizinischen Universitätsklinik und Poliklinik V
University of Heidelberg
Heidelberg, Germany

Roman Hájek, MD
University Hospital Brno
Brno, Czech Republic
Joy Ho, MD
Royal Prince Alfred Hospitals
and Concord Hospitals
Camperdown, Australia

Vania Hungria, MD
Clinica São Germano
São Paulo, Brazil
Sundar Jagannath, MD
Mt Sinai Cancer Institute
New York, NY
U.S.A.

Douglas Joshua, MD
Royal Prince Alfred Hospital
Camperdown, NSW, Australia
Michio M. Kawano, MD
Graduate School of Medicine
Yamaguchi University
Yamaguchi, Japan

Jae-Hoon Lee
GACHON University GIL Hospital
Division of Hematology/Oncology
Incheon, South Korea
Henk M. Lokhorst, MD
University Hospital Utrecht
Utrecht, Netherlands

Sagar Lonial, MD
Winship Cancer Institute
Emory University
Atlanta, GA
USA
Heinz Ludwig, MD
Wilhelminenspital der Stadt Wein
Vienna, Austria

Jayesh Mehta, MD
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, IL
U.S.A.
Håken Mellstedt, MD, PhD
Karolinska Hospital
Stockholm, Sweden

Giampaolo Merlini, MD
Amyloidosis Centre
Università di Pavia
Pavia, Italy
Gareth Morgan, MD
The Royal Marsden Hospital
Sutton, Surrey, UK

Nikhil Munshi, MD
Dana Farber Cancer Institute
Boston MA, USA
Amara Nouel, MD
Hospital Rutz y Paez
Bolivar, Venezuela

Antonio Palumbo, MD
Ospedale Molinette
Torino, Italy
and Italian Multiple Myeloma Study Group (GISMM
Linda Pilarski, PhD
Cross Cancer Institute
University of Alberta
Edmonton, Alberta, Canada

Raymond Powles, MD
Leukaemia and Myeloma Units
Parkside Oncology Clinic
London, U.K.
S. Vincent Rajkumar, MD
Mayo Clinic College of Medicine
Rochester, MN
U.S.A.

Donna E. Reece, MD
Princess Margaret Hospital
Toronto, Canada
Paul G. Richardson, MD
Dana Farber Cancer Institute
Boston, MA
U.S.A.

Angelina Rodriguez Morales, MD
Banco Municipal de Sangre de la Region Capital
Caracas,Venezuela
David Roodman, MD
VA Medical Hospital
Pittsburgh, PA
U.S.A.

Jesús San Miguel, MD
Hospital Clinico Universitario
Universidad de Salamanca
Salamanca, Spain
Orhan Sezer, MD
University of Hamburg
Hamburg, Germany

Kazayuki Shimizu, MD
Nagoya City Higashi General Hospital
Nagoya, Japan
Chaim Shustik, MD
Royal Victoria Hospital
McGill University Clinical Research Program
Montreal, Canada

David Siegel, MD
John Theurer Cancer Center
Hackensack University Medical Center
Hackensack, New Jersey USA
Seema Singhal, MD
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, IL
U.S.A.

Alan Solomon, MD
University of Tennessee Medical Center
Knoxville, TN
U.S.A.
Pieter Sonneveld, MD
University Hospital Rotterdam Dijkzigt
Rotterdam, The Netherlands

Andrew Spencer, MD
Cabrini Hospital
Malvern, Victoria
Australia
A. Keith Stewart, MD
Mayo Clinic
Scottsdale, AZ, USA

Guido Tricot, MD
Huntsman Cancer Institute
Salt Lake City, Utah
USA
Benjamin Van Camp, MD, PhD
Academic Hospital
Free University of Brussels
Brussels, Belgium

Brian Van Ness, Ph.D.
University of Minnesota
Institute of Human Genetics
Minneapolis, MN
U.S.A.
David Vesole, MD
John Theurer Cancer Center
Hackensack University Medical Center
Hackensack, New Jersey USA>

Jan Westin, MD
Department of Hematology
Sahlgrenska University Hospital
Gothenburg University, Sweden